SMAD2 and urinary bladder cancer: The presence of SMAD2 C-terminal mutations caused an 80% reduction in overall tumour growth formation thus underscoring the role for TGFβ signalling in bladder cancer tumourigenesis (Supplementary Fig. 13a–c).